Headache profiles of patients who were referred to neurology clinics: A subgroup analysis of the Head-MENAA study

被引：0
|
作者：
Genc, Hamit [1 ]
Bolay, Hayrunnisa [2 ]
Baykan, Betul [3 ]
Uluduz, Derya [4 ]
Unal-Cevik, Isin [5 ]
Kissani, Najib [6 ]
Luvsannorov, Otgonbayar [7 ]
Togha, Mansoureh [8 ]
Ozdemir, Asena Ayca [9 ]
Ozge, Aynur [10 ]
机构：
[1] Gaziantep Dr Ersin Arslan Training & Res Hosp, Gaziantep, Turkiye
[2] Gazi Univ, Fac Med, Dept Neurol & Algol, NOROM, Ankara, Turkiye
[3] Istanbul Univ, EMAR Med Ctr, Istanbul Fac Med, Istanbul, Turkiye
[4] Istanbul Univ, Cerrahpasa Fac Med, Istanbul, Turkiye
[5] Hacettepe Univ, Fac Med, Ankara, Turkiye
[6] Cadi Ayyad Univ, Neurosci Res Lab Marrakesh Med Sch, Marrakech, Morocco
[7] Mongolian Natl Univ Med Sci, Ulaanbaatar, Mongolia
[8] Univ Tehran Med Sci, Tehran, Iran
[9] Mersin Univ, Dept Biostat & Med Informat, Mersin, Turkiye
[10] Mersin Univ, Fac Med, Mersin, Turkiye
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
Head-MENAA study; primary headaches; neurology clinics; disease control; emergency service; other services; private office;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-1
引用
收藏
页码：151 / 152
页数：2
相关论文
共 50 条
  • [21] The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study
    Gok, Gulay
    Sinan, Umit Yasar
    Ozyuncu, Nil
    Zoghi, Mehdi
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2018, 46 (04): : 283 - 295
  • [22] Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)
    Kinos, Sampsa
    Hagman, Helga
    Halonen, Paivi
    Soveri, Leena-Maija
    O'Reilly, Mary
    Pfeiffer, Per
    Froedin, Jan-Erik
    Sorbye, Halfdan
    Heerva, Eetu
    Liposits, Gabor
    Kallio, Raija
    Algars, Annika
    Ristamaki, Raija
    Salminen, Tapio
    Barlund, Maarit
    Shah, Carl-Henrik
    Mcdermott, Ray
    Rockert, Rebecka
    Flygare, Petra
    Kwakman, Johannes
    Teske, Arco J.
    Punt, Cornelis
    Glimelius, Bengt
    Osterlund, Pia
    ACTA ONCOLOGICA, 2024, 63 : 248 - 258
  • [23] TREATMENT COMBINED WITH BONE-MARROW TRANSPLANTATION FOR ADVANCED NEUROBLASTOMA - AN ANALYSIS OF PATIENTS WHO WERE PRETREATED INTENSIVELY WITH THE PROTOCOL OF THE STUDY-GROUP OF JAPAN
    OHNUMA, N
    TAKAHASHI, H
    KANEKO, M
    UCHINO, J
    TAKEDA, T
    IWAFUCHI, M
    OHHIRA, M
    NISHIHIRA, H
    MUGISHIMA, H
    YOKOYAMA, J
    OKADA, A
    NAGAHARA, N
    TAGUCHI, N
    TSUCHIDA, Y
    MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (03): : 181 - 187
  • [24] Accidental Pathological Findings in Asymptomatic Maxillary Sinuses in Patients Referred for Head and Neck Cone-Beam Computed Tomography: A Cross-sectional Study Analysis
    Chandran, Ajay
    Patil, Manisha B.
    Nachiappan, S.
    Panwar, Pratyaksha Singh
    Nagarajappa, Anil Kumar
    Kolte, Deepak R.
    Babu, J. Suresh
    Swarnalatha, C.
    Nayyar, Abhishek Singh
    JOURNAL OF MEDICAL SIGNALS & SENSORS, 2022, 12 (02): : 138 - 144
  • [25] Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: Subgroup analysis of a randomized, double-blind, multicenter, phase 3 study (SIRROUND-T)
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Harigai, Masayoshi
    Yamanaka, Hisashi
    Nakano, Toshikazu
    Akagi, Koshiro
    Ukyo, Yoshifumi
    Hsu, Benjamin
    MODERN RHEUMATOLOGY, 2019, 29 (02) : 306 - 313
  • [26] Botulinum toxin type A for the prophylaxis of chronic daily headache: Subgroup analysis of patients not receiving other prophylactic medications: A randomized double-blind, placebo-controlled study
    Dodick, DW
    Mauskop, A
    Elkind, AH
    DeGryse, R
    Brin, MF
    Silberstein, SD
    HEADACHE, 2005, 45 (04): : 315 - 324
  • [27] Botulinum toxin type a for the prophylaxis of chronic daily headache: Subgroup analysis of patients not receiving other prophylactic medications - (A randomized double-blind, placebo-controlled study)
    Dodick, DW
    Mauskop, A
    Elkind, AH
    DeGryse, R
    Brin, MF
    Silberstein, SD
    NEUROLOGY, 2005, 64 (06) : A422 - A422
  • [28] The Prevalence of Symptoms and Diagnosis of Attention-Deficit Hyperactivity Disorder Among Adult Female Patients with Mild / Moderate Major Depressive Disorder Who Were Referred to the Psychiatric Outpatient Department of a Training Hospital: A Preliminary Study
    Bosgelmez, Sukriye
    Tufan, Ali Evren
    DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, 2014, 27 (01): : 27 - 33
  • [29] Thrombectomy is Safe for Dawn- and Defuse-3-Ineligible Patients Who Present Within the Extended Window: A Subgroup Analysis From the BEST Prospective Cohort Study
    Siegler, James E.
    Messe, Steven R.
    Sucharew, Heidi
    Mehta, Tapan
    Arora, Niraj
    Starosciak, Amy K.
    La Rosa, De Los Rios Felipe
    Barnhill, Natasha R.
    Mistry, Akshitkumar M.
    Patel, Kishan
    Assad, Salman
    Tarboosh, Amjad
    Dakay, Katarina
    Wagner, Jeff
    Bennett, Alicia
    Jagadeesan, Bharathi
    Streib, Christopher
    Weber, Stewart A.
    Chitale, Rohan
    Volpi, John J.
    Mayer, Stephan A.
    Yaghi, Shadi
    Jayaraman, Mahesh
    Khatri, Pooja
    Mistry, Eva
    STROKE, 2019, 50
  • [30] Botulinum toxin type A for the prophylaxis of chronic daily headache (CDH) in migraineurs: Subgroup analysis of patients not receiving other prophylactic medications (A randomized, double-blind, placebo-controlled study)
    Dodick, DW
    Mauskop, A
    Elkind, AH
    DeGryse, R
    Brin, MF
    Silberstein, SD
    HEADACHE, 2005, 45 (06): : 774 - 774
12345